CBD PR strategy in 2026 means earning coverage through education and transparency, not paid ads, since the 2025 Hemp Bill takes effect in November and reclassifies hemp by total THC instead of delta-9 only. Brands that built compliance programs around the old 2018 Farm Bill definition now need new testing, new claims language, and new media relationships before the rule takes hold. The agencies that move first capture the coverage; the ones that wait spend 2027 explaining a recall.
What changes for CBD brands when the Hemp Bill takes effect?
The 2025 Hemp Bill takes effect in November 2026 and judges hemp by total THC content rather than delta-9 THC alone, a change reported by the Washington Post on November 13, 2025. Under the 2018 Farm Bill, a product only needed to stay under 0.3% delta-9 THC by dry weight to qualify as legal hemp. Many CBD products formulated under that standard will no longer qualify once the new rule applies.
Brands that have not retested their formulations against the new total-THC standard are exposed to FDA warning letters and retailer delisting the day the rule takes effect. A CBD PR program built for 2026 starts with a compliance review, not a press release.
Why does paid advertising fail CBD brands right now?
Paid advertising fails CBD brands because Google, Meta, and TikTok restrict or block CBD promotion outright, forcing brands that rely on paid social and search to lose reach overnight when an account gets flagged. A CBD marketing report from Bigeye published January 23, 2026 found that even compliant brands face ad rejections and sudden account suspensions, which pushed the industry from a paid acquisition model toward owned media and earned coverage.
5W's own cannabis and CBD practice reflects the same shift. The firm's cannabis marketing work for cannabis and CBD clients centers on PR, SEO, and influencer programs precisely because paid channels are unreliable for this category, not because earned media is a fallback choice.
How does 5W secure coverage for CBD brands without paid claims?
5W secures CBD coverage by positioning named internal experts as sources for trade and consumer press instead of leading with product claims. When 5W launched its CBD-focused team in December 2018, Vice President Alise Edgcomb told the firm that beauty editors respond to CBD stories framed around self-care and personal experience rather than the cannabis angle itself, and that partnering with an agency that has direct editor relationships lets brands reach writers who are already open about conditions like anxiety or skin sensitivity.
Associate Vice President Jacolyn Gleason has raised the same constraint from the health and wellness side: CBD companies are regulated by the FDA and cannot make treatment claims, so building direct relationships with health and wellness media becomes the mechanism for getting factual, compliant information in front of readers instead of relying on advertising to do that work.
What proof shows this approach works for cannabis and CBD clients?
5W's cannabis practice reports two verifiable results from named clients. The firm's work for Columbia Care, now operating as The Cannabist Company, generated more than 478.9 million media impressions in its first year, with coverage in Forbes, Bloomberg, and the Associated Press. Its partnership with cbdMD delivered more than 998 million media impressions and 130 placements across Business Insider, CNN Business, and Rolling Stone.
Both results came from earned coverage, not paid placement, which is the same channel every CBD brand is now forced toward by platform restrictions. A specialized cannabis PR practice built those relationships over years; a generalist agency treating cannabis as a side vertical has to build them from zero after the Hemp Bill takes effect.
What should a CBD brand's PR program prioritize in 2026?
A CBD brand's PR program should prioritize retested compliance claims, named expert sources, and education-first content over lifestyle messaging or paid amplification. The table below breaks down where budget and attention should move.
| Priority | Why it matters now | What it replaces |
|---|---|---|
| Retested compliance claims | The Hemp Bill's total-THC standard takes effect in November 2026 and invalidates claims built on the old delta-9-only rule | Legacy dry-weight delta-9 testing |
| Named expert sources | Editors want a person who can explain the endocannabinoid system and sourcing standards in plain language, not a press release | Unattributed brand statements |
| Owned education content | Bigeye's 2026 report found owned channels are the most reliable growth path once paid CBD ads get restricted | Paid social and search campaigns |
| Earned trade and consumer coverage | 5W's cbdMD and Columbia Care results came entirely from earned placements, not paid media | Influencer paid partnerships alone |
CONCLUSION
CBD PR in 2026 comes down to compliance first, named experts second, and earned coverage over paid reach, because the Hemp Bill removes the old shortcuts and the platforms already removed the paid ones. 5W runs cannabis and CBD PR programs for brands including CBDistillery, HighHemp, Columbia Care, and cbdMD, building the compliance-first campaigns and media relationships this shift requires. Learn more at 5wpr.com/practice/cannabis-marketing-agency.cfm.
